Gamco Investors INC. ET AL purchased a new position in shares of Teladoc Inc (NYSE:TDOC) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 27,000 shares of the health services provider’s stock, valued at approximately $941,000.

Several other institutional investors and hedge funds have also made changes to their positions in TDOC. Nationwide Fund Advisors increased its stake in shares of Teladoc by 126.7% during the 2nd quarter. Nationwide Fund Advisors now owns 30,495 shares of the health services provider’s stock worth $1,058,000 after purchasing an additional 17,046 shares during the last quarter. BlackRock Inc. increased its stake in shares of Teladoc by 42.9% during the 2nd quarter. BlackRock Inc. now owns 3,844,402 shares of the health services provider’s stock worth $133,400,000 after purchasing an additional 1,154,852 shares during the last quarter. New York State Common Retirement Fund increased its stake in shares of Teladoc by 74.2% during the 2nd quarter. New York State Common Retirement Fund now owns 67,959 shares of the health services provider’s stock worth $2,358,000 after purchasing an additional 28,944 shares during the last quarter. Northern Trust Corp increased its stake in shares of Teladoc by 96.8% during the 2nd quarter. Northern Trust Corp now owns 677,949 shares of the health services provider’s stock worth $23,525,000 after purchasing an additional 333,452 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of Teladoc by 11.5% during the 2nd quarter. Vanguard Group Inc. now owns 3,041,725 shares of the health services provider’s stock worth $105,547,000 after purchasing an additional 314,646 shares during the last quarter.

Teladoc Inc (NYSE:TDOC) opened at $33.80 on Tuesday. Teladoc Inc has a 12 month low of $19.60 and a 12 month high of $38.40. The company has a quick ratio of 5.08, a current ratio of 5.08 and a debt-to-equity ratio of 0.83. The stock has a market cap of $2,050.00 and a price-to-earnings ratio of -23.31.

In other Teladoc news, CFO Mark Hirschhorn sold 30,000 shares of the stock in a transaction on Monday, December 4th. The shares were sold at an average price of $32.99, for a total value of $989,700.00. Following the completion of the sale, the chief financial officer now directly owns 5,203 shares of the company’s stock, valued at approximately $171,646.97. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Jason N. Gorevic sold 100,000 shares of the stock in a transaction on Monday, December 4th. The shares were sold at an average price of $32.99, for a total transaction of $3,299,000.00. Following the completion of the sale, the chief executive officer now directly owns 718,261 shares of the company’s stock, valued at $23,695,430.39. The disclosure for this sale can be found here. 4.47% of the stock is owned by corporate insiders.

A number of research analysts recently issued reports on the stock. Zacks Investment Research lowered shares of Teladoc from a “buy” rating to a “hold” rating in a research note on Wednesday, October 18th. SunTrust Banks reiterated a “buy” rating and issued a $40.00 target price on shares of Teladoc in a research note on Friday, November 3rd. BidaskClub lowered shares of Teladoc from a “hold” rating to a “sell” rating in a research note on Wednesday, November 15th. Canaccord Genuity set a $42.00 target price on shares of Teladoc and gave the company a “buy” rating in a research note on Friday, November 17th. Finally, Cantor Fitzgerald reiterated a “hold” rating and issued a $31.00 target price on shares of Teladoc in a research note on Monday, November 20th. One analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have given a buy rating to the company. Teladoc presently has a consensus rating of “Buy” and a consensus target price of $39.43.

ILLEGAL ACTIVITY NOTICE: “27,000 Shares in Teladoc Inc (TDOC) Acquired by Gamco Investors INC. ET AL” was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://theolympiareport.com/2018/02/13/27000-shares-in-teladoc-inc-tdoc-acquired-by-gamco-investors-inc-et-al.html.

Teladoc Company Profile

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.